These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 26945264

  • 1. Hemopericardium under dabigatran for stroke prevention in atrial fibrillation.
    Stöllberger C, Heger M, Finsterer J.
    Blood Coagul Fibrinolysis; 2017 Mar; 28(2):185-188. PubMed ID: 26945264
    [Abstract] [Full Text] [Related]

  • 2. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
    Toyoda K, Arihiro S, Todo K, Yamagami H, Kimura K, Furui E, Terasaki T, Shiokawa Y, Kamiyama K, Takizawa S, Okuda S, Okada Y, Kameda T, Nagakane Y, Hasegawa Y, Mochizuki H, Ito Y, Nakashima T, Takamatsu K, Nishiyama K, Kario K, Sato S, Koga M, SAMURAI Study Investigators.
    Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
    [Abstract] [Full Text] [Related]

  • 3. Impact of Variations in Kidney Function on Nonvitamin K Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Recent Acute Heart Failure.
    Andreu-Cayuelas JM, Pastor-Pérez FJ, Puche CM, Mateo-Martínez A, García-Alberola A, Flores-Blanco PJ, Valdés M, Lip GY, Roldán V, Manzano-Fernández S.
    Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):134-40. PubMed ID: 26607030
    [Abstract] [Full Text] [Related]

  • 4. Dabigatran-Induced Spontaneous Hemopericardium and Cardiac Tamponade.
    Jelani QU, Gordon R, Schussheim A.
    Tex Heart Inst J; 2017 Oct; 44(5):370-372. PubMed ID: 29259514
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
    Maura G, Blotière PO, Bouillon K, Billionnet C, Ricordeau P, Alla F, Zureik M.
    Circulation; 2015 Sep 29; 132(13):1252-60. PubMed ID: 26199338
    [Abstract] [Full Text] [Related]

  • 6. [Should dabigatran or vitamin K antagonists be used in prevention of stroke in patients with atrial fibrillation?].
    Calvo Romero JM.
    Rev Clin Esp; 2011 Mar 29; 211(3):142-6. PubMed ID: 21371701
    [Abstract] [Full Text] [Related]

  • 7. Hemopericardium in a patient treated with dabigatran etexilate.
    Barton CA, McMillian WD, Raza SS, Keller RE.
    Pharmacotherapy; 2012 May 29; 32(5):e103-7. PubMed ID: 22488474
    [Abstract] [Full Text] [Related]

  • 8. [Serious bleeding as a consequence of accumulation of dabigatran caused by renal failure].
    Skjødt-Jensen AM, Hvas AM.
    Ugeskr Laeger; 2014 Jun 09; 176(24):. PubMed ID: 25352200
    [Abstract] [Full Text] [Related]

  • 9. Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.
    Brunetti L, Chen C, White J.
    Consult Pharm; 2014 Mar 09; 29(3):169-78. PubMed ID: 24589766
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry.
    Beyer-Westendorf J, Ebertz F, Förster K, Gelbricht V, Michalski F, Köhler C, Werth S, Endig H, Pannach S, Tittl L, Sahin K, Daschkow K, Weiss N.
    Thromb Haemost; 2015 Jun 09; 113(6):1247-57. PubMed ID: 25739533
    [Abstract] [Full Text] [Related]

  • 11. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
    Zalesak M, Siu K, Francis K, Yu C, Alvrtsyan H, Rao Y, Walker D, Sander S, Miyasato G, Matchar D, Sanchez H.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):567-74. PubMed ID: 23922182
    [Abstract] [Full Text] [Related]

  • 12. Challenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A Review.
    Alcocer L.
    Am J Cardiovasc Drugs; 2016 Jun 01; 16(3):171-82. PubMed ID: 26923792
    [Abstract] [Full Text] [Related]

  • 13. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013.
    Olesen JB, Sørensen R, Hansen ML, Lamberts M, Weeke P, Mikkelsen AP, Køber L, Gislason GH, Torp-Pedersen C, Fosbøl EL.
    Europace; 2015 Feb 01; 17(2):187-93. PubMed ID: 25236181
    [Abstract] [Full Text] [Related]

  • 14. Novel Anticoagulants in Atrial Fibrillation: A Primer for the Primary Physician.
    Mookadam M, Shamoun FE, Mookadam F.
    J Am Board Fam Med; 2015 Feb 01; 28(4):510-22. PubMed ID: 26152444
    [Abstract] [Full Text] [Related]

  • 15. Dabigatran for the prevention and treatment of thromboembolic disorders.
    Enriquez A, Baranchuk A, Redfearn D, Simpson C, Abdollah H, Michael K.
    Expert Rev Cardiovasc Ther; 2015 May 01; 13(5):529-40. PubMed ID: 25843430
    [Abstract] [Full Text] [Related]

  • 16. Dabigatran and warfarin for secondary prevention of stroke in atrial fibrillation patients: a nationwide cohort study.
    Larsen TB, Rasmussen LH, Gorst-Rasmussen A, Skjøth F, Lane DA, Lip GY.
    Am J Med; 2014 Dec 01; 127(12):1172-8.e5. PubMed ID: 25193361
    [Abstract] [Full Text] [Related]

  • 17. [Anticoagulation for patients with non-valvular atrial fibrillation].
    Mizoguchi T, Yasaka M.
    Nihon Rinsho; 2016 Apr 01; 74(4):627-33. PubMed ID: 27333751
    [Abstract] [Full Text] [Related]

  • 18. Is Dabigatran As Effective As Warfarin on Cardiac Thrombus in a Patient With Atrial Fibrillation? A Challenging Question.
    Sunbul M, Cincin A, Mammadov C, Mutlu B.
    Am J Ther; 2016 Apr 01; 23(3):e974-6. PubMed ID: 25415546
    [Abstract] [Full Text] [Related]

  • 19. Safety of early initiation of rivaroxaban or dabigatran after thrombolysis in acute ischemic stroke.
    Ritzenthaler T, Derex L, Davenas C, Bnouhanna W, Farghali A, Mechtouff L, Cho TH, Nighoghossian N.
    Rev Neurol (Paris); 2015 Sep 01; 171(8-9):613-5. PubMed ID: 25857461
    [Abstract] [Full Text] [Related]

  • 20. Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.
    Fieland D, Taylor M.
    Ann Pharmacother; 2012 Jan 01; 46(1):e3. PubMed ID: 22202498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.